Cancer drugs fund cuts 23 treatments
Want your say? then simply register with our #incontinence and #health forum
The Cancer Drugs Fund in England will no longer pay for 16 medicines, used in 23 separate cancer treatments.
It has now more than halved the number of treatments it covers since the beginning of the year after being repeatedly overspent.
The latest drugs being axed include those for breast, pancreatic and blood cancers.
The Rarer Cancers Foundation said the news was a "hammer blow" and estimated that 5,500 patients would miss out.
Patients affected
Blood cancer - 1,759 patients
Breast cancer - 986 patients
Bowel cancer - 845 patients
Prostate cancer - 601 patients
Upper gastrointestinal cancer - 549 patients
Urological cancer - 376 patients
Brain and central nervous system - 229 patients
Gynaecological cancer - 188 patients
Andrew Wilson, chief executive of the Rarer Cancers Foundation which is supported by pharmaceutical companies, said: "These cuts will be a hammer blow to many thousands of desperately ill cancer patients and their families.
Social bookmarking
feeds
No Comment.